Paragon 28 downgraded to Market Perform from Outperform at William Blair

William Blair downgraded Paragon 28 (FNA) to Market Perform from Outperform without a price target after the company entered into a definitive agreement for Zimmer Biomet to acquire all its outstanding shares for $13.00 in cash, corresponding to an equity value of approximately $1.1B.